Make influenza prevention a year-round part of your practice
Educate about the seriousness of influenza
The only influenza vaccine licensed for use in persons 6 months of age and older
Fluzone vaccine is indicated in persons 6 months of age and older for active immunization against influenza virus types A and B contained in the vaccine.
The most common local and systemic adverse reactions to Fluzone vaccine include soreness at the vaccination site that can last up to 2 days, pain, and swelling; fever, malaise, and myalgia. Other adverse reactions may occur. Influenza vaccine should not be administered to anyone with a history of hypersensitivity to any vaccine component, including eggs, egg products, or thimerosal (the only presentation that contains thimerosal is the multi-dose vial). Fluzone vaccine should not be administered to individuals who have a prior history of Guillain-Barré syndrome (GBS). Vaccination with Fluzone vaccine may not protect all individuals.
Before administering Fluzone vaccine, please see full prescribing information.For the MSDS sheet click here.